David Evans
Analyst · Doug Anmuth with JPMorgan
Thanks Lynne. As Scott mentioned, we delivered very strong third quarter results that exceeded our expectations. And we are therefore raising our full year 2019 guidance based on our strong results and the momentum in our business. We are tracking very well to the plan that we have been communicating to investors over the last several quarters. I'll begin by commenting on our third quarter, and we'll then discuss our fourth quarter and full year 2019 financial outlook. Total billings, which is the gross amount billed to marketers inclusive of the consumer incentive, for the third quarter increased 70% year-over-year to $82.8 million. Total revenue for the third quarter was $56.4 million, representing 63% year-over-year growth. Total U.S. revenue increased 65% year-over-year, and U.K. revenue increased 47% year-over-year. Adjusted contribution profit was $24.7 million in the third quarter of 2019, up 46% year-over-year and up 53% if you exclude an $800,000 benefit from the Lloyds contract in Q3 2018. Adjusted EBITDA was positive $3 million in the third quarter of 2019. This is compared to a loss of $1.7 million in the third quarter of 2018. We are pleased with our adjusted EBITDA results in Q3, which is reflective of the operating leverage which we anticipated coming through our business model in the second half of this year. While we continue to expect to see the benefits from a fixed costs business on our profitability moving forward, we believe it's also important to highlight that we will continue to make strategic investments across our business to capture the significant growth opportunities we see for Cardlytics in the market today. As a result, our adjusted EBITDA will likely experience some fluctuation from quarter to quarter in the future. Average FI MAUs grew 116% from 59.3 million in the third quarter of 2018 to 128.3 million in Q3 2019 primarily reflecting the launch of Chase. Looking to 2020, we expect additional FI MAU growth from the phased launch of Wells Fargo in addition to continued growth in FI MAUs through the natural maturation in the network, our ongoing efforts with FI partners and digital adoption. Our third quarter 2019 ARPU was $0.44, down approximately 24% from $0.58 in the third quarter of 2018, but up 10% from $0.40 in the second quarter of 2019. As expected, our year-over-year ARPU decline primarily reflects the impact of rapid growth in our average FI MAUs. We expect this dynamic to play out for the near term and continue with the growth in our FI MAUs that will come from the Wells Fargo rollout. Moving to our balance sheet and the impacts from the follow-on offering completed in September. On September 13th, we successfully completed and closed a follow-on offering in which we sold 1.9 million shares and selling stockholders sold 1.2 million shares, which resulted in approximately $61 million net proceeds to the company after deducting underwriting discounts and commissions and expenses. We believe this capital raise provides increased strategic and financial flexibility to execute on our long-term strategic goals. We also received $19.2 million in proceeds from the exercise of options and warrants to put the shares of common stock in the third quarter. With that, we ended the quarter with $95.2 million in cash, $246,000 in restricted cash on the balance sheet compared to $32.5 million in cash and $10.3 million in restricted cash at the end of Q2 2019. We also ended the quarter with effectively zero debt outstanding. In the third quarter, we eliminated the balance of our 2018 term loan using the $10 million of restricted cash on our balance sheet during the loan. In addition, we used the cash on hand to pay down the $26.7 million outstanding on our $40 million AR facility, which remains fully available for us to borrow against. As a result, our total cash plus available dollars to us in our credit facility as of September 30th, 2019, was approximately $135 million. We ended the quarter with 25.7 million shares outstanding and quarter to date weighted shares outstanding for the quarter of 23.6 million compared to 22.8 million outstanding at the end of the second quarter. The difference in common shares outstanding relative to the June 30th, 2019 number reflects the increase of 1.9 million of primary shares due to the follow-on and 1 million shares from the exercise of warrants and options made during the quarter. Now, turning to guidance, for the fourth quarter, we expect billings to grow 17% to 25% year-over-year to between $82 million and $88 million. We expect GAAP revenue to be between $55 million and $59 million. And we expect adjusted contribution profit for the fourth quarter to be between $23.5 million and $25.5 million representing 15% to 23% revenue growth and 6% to 15% adjusted contribution growth year-over-year. Finally, we expect adjusted EBITDA for the fourth quarter to be between $1 and $2 million. For full year 2019, we are raising our guidance. We expect billings growth of 36% to 38% to be between $297 million and $303 million. We currently expect GAAP revenue to be between $196 million and $200 million and adjusted contribution for 2019 to be between $87.5 million and $89.5 million, representing 30% to 33% revenue growth and 26% to 29% adjusted contribution growth for 2019. We also expect adjusted EBITDA for full year 2019 to be between $0 million and $1 million. Overall, we are pleased with our strong third quarter and year-to-date 2019 results. We continue to see good momentum in our business, driven by increasing demand for our platform and strong execution against our key growth strategy, including our efforts to expand advertising budgets with existing marketers and drive deeper penetration into new verticals. With that, I'll hand it back to Scott for his closing remarks before we open the call to your questions. Scott?